Arcutis Biotherapeutics, Inc.
ARQT
Ранг среди акций
#4009
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Цена акции
$32.58
Рыночная капитализация
$4.09B
Изменение (1 день)
2.15%
Изменение (1 год)
56.02%
Страна
US
Торговля Arcutis Biotherapeutics, Inc. (ARQT)
Категория
Healthcare
Коэффициент P/B для Arcutis Biotherapeutics, Inc. (ARQT)
Коэффициент P/B на October 2026 TTM: 15.63
Согласно последним финансовым отчетам и цене акций Arcutis Biotherapeutics, Inc., текущий коэффициент P/B (TTM) составляет 15.63. В конце 2023 он составлял 2.52.
История P/B для Arcutis Biotherapeutics, Inc. с 2017 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| 2026 (TTM) | 15.63 | 46.05% |
| 2024 | 10.70 | 323.63% |
| 2023 | 2.52 | -35.03% |
| 2022 | 3.89 | 12.90% |
| 2021 | 3.44 | -7.15% |
| 2020 | 3.71 | -129.04% |
| 2019 | -12.77 | -61.23% |
| 2018 | -32.93 | 614.27% |
| 2017 | -4.61 | 0.00% |
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| 6.251 | -60.00% |
US
|
|
| 13.2547 | -15.18% |
US
|
|
| 4.208 | -73.07% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | -60.44% |
NL
|
